About ZIG Ventures
ZIG Ventures is a venture capital firm founded in 2014. It is primarily based out of Singapore, Singapore. As of Apr 2026, ZIG Ventures has invested in 6 companies. It primarily invests in Series A round in Singapore based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and Enterprise Applications. Most recently it participated in the $***** Series C round of Biobot Surgical Overall, ZIG Ventures portfolio has seen 1 IPO and 1 acquisition, namely Curiox and BELKIN Vision. A lot of funds co-invest with ZIG Ventures, with names like OCBC sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Rounds of Entry
Series A & Series B
Portfolio IPOs
Portfolio Acquisitions
Deals in last 12 months
ZIG Ventures' List of Top Investments
ZIG Ventures has a portfolio of 6 companies. Their most notable investments are in BELKIN Vision and Endofotonics.Their portfolio spans across Singapore, Israel and South Korea. They have invested in Life Sciences, HealthTech, Enterprise Applications and 2 other sectors, across stages such as Series A, Series B stages. Here is the list of top investments by ZIG Ventures:1. HistoIndex
Provider of AI powered digital pathology platform for fibrosis analysis. The platform utilizes Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) microscopy to capture high-resolution images of unstained tissue samples to quantify fibrosis and other morphological features. The technology accelerates therapeutic development and clinical trial by providing translatable data from preclinical studies to clinical trials and enhancing clinical diagnostics. It supports advancements and regulatory approvals across the drug development and clinical diagnostic value chain.
Key facts about HistoIndex
- Founded Year: 2010
- Location: Singapore (Singapore)
- Stage: Series A
- Total Funding till date: $6.89M
- Employee Count: 20 as on Jul 01, 2024
- Investors: ZIG Ventures, SEEDS Capital and 2 Others
- Latest Funding Round: Series A, May 01, 2025, $*****
- Highlight: Editors' Pick
Developer of surgical automation devices. The products include robotic transperineal biopsy device (rTPB), developed through collaborative partnership that enables surgeons to extract prostate biopsy tissues through 2 small needle puncture incisions on the perineal skin.
Key facts about Biobot Surgical
- Founded Year: 2010
- Location: Singapore (Singapore)
- Annual Revenue: SGD 1M - 10M as on Jun 30, 2024
- Stage: Series C
- Total Funding till date: $25.7M
- Employee Count: 46 as on May 31, 2026
- Investors: ZIG Ventures, Clavystbio and 6 Others
- Latest Funding Round: Series C, Apr 09, 2026, $*****
- Highlight: Editors' Pick
3. Curiox
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. The company has designed wall-less plates and washers to automate miniaturized cell-based assays. This novel DropArray technology can be miniaturized down to 5ul with minimal changes to the customer workflow. Its products include DropArray Microplate, HT200 Washing Station, and LT210 Washing Station.
Key facts about Curiox
- Founded Year: 2007
- Location: Seoul (South Korea)
- Stage: Public
- Total Funding till date: $30M
- Employee Count: 62 as on May 31, 2026
- Investors: QUAD, QUAD and 13 Others
- Latest Funding Round: Series C, Mar 16, 2022, $*****
- Highlight: Public
Developer of a laser device for the treatment of glaucoma. The company's device Vision DSLT offers non-invasive, non-contact, and painless laser therapy. This device delivers laser beam to the limbus which enhances intraocular fluid drainage and lowers the pressure. It helps in the treatment of open-angle glaucoma and angle-closure glaucoma.
Key facts about BELKIN Vision
- Founded Year: 2013
- Location: Yavne (Israel)
- Stage: Acquired
- Total Funding till date: $16.2M
- Employee Count: 20 as on Jul 01, 2024
- Investors: ZIG Ventures, Santen Pharmaceuticals and 6 Others
- Latest Funding Round: Grant (prize money), Jan 01, 2022, $*****
- Highlight: Acquired
5. Endofotonics
Endophotonics is a medical device company that has developed an endoscopic system based on Raman Spectroscopy. The IMDX system consists of a Raman Spectroscope, a proprietary specially designed fibre-optic confocal Raman endoscopic probe that comprises a central light delivery fibre for laser light delivery and collection fibres for in vivo tissue Raman signal collection of tissue spectra and can be inserted into the instrument channel of conventional endoscopes and a proprietary control software that enables epithelial molecular information to be extracted and analyzed in real-time. Spectral information acquired by the system is matched against a database to quick diagnosis.
Key facts about Endofotonics
- Founded Year: 2014
- Location: Singapore (Singapore)
- Stage: Series B
- Total Funding till date: $8.5M
- Employee Count: 2 as on May 31, 2026
- Investors: ZIG Ventures, Harleys Investments and 22 Others
- Latest Funding Round: Series B, May 28, 2020, $*****
- Highlight: Editors' Pick
ZIG Ventures' Year-on-Year Investment Trends
ZIG Ventures has invested in 6 companies over the last 10 years, with an average of 0 new investment annually in the last 10 years. In 2025, it made 1 investment, while as of Apr 2026, it has made 1 investment in this year. Its most recent first time investment was in HistoIndex and most recent follow-on round was in Biobot Surgical.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 1 | 1 |
2025 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
2023 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 |
2020 | 0 | 0 | 0 |
2019 | 0 | 0 | 0 |
2018 | 0 | 0 | 0 |
2017 | 1 | 0 | 1 |
ZIG Ventures' Investments by Stage
ZIG Ventures has made 3 investments in Series A stage with an average round size of $4.69M and 1 investment in Series B stage with an average round size of $17.9M.Stage of entry | No. of Investments |
|---|---|
Series A | 3 |
Series B | 1 |
Note: We have considered here, only first round of investments
ZIG Ventures' Investments by Sector
ZIG Ventures has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Enterprise Applications, HealthTech and Robotics - Industry Applications. Notably, it has invested in 6 Enterprise (B2B) companies, 6 Tech companies, 5 Tech hardware companies and at least 3 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 4 |
High Tech | 2 |
Enterprise Applications | 1 |
HealthTech | 1 |
Robotics - Industry Applications | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
ZIG Ventures' Investments by Geography
ZIG Ventures has made most investments in Singapore (3), followed by Israel where it has made 1 investment.Country | No. of Investments |
|---|---|
Singapore | 3 |
Israel | 1 |
Note: We have considered here, only first round of investments
ZIG Ventures' recent investments
ZIG Ventures has made 1 investments in 2026 so far - Biobot Surgical.Here are the most recent investments by ZIG Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 09, 2026 | Singapore | Series C | 7087 | ||
May 01, 2025 | Singapore | Series A | 6302 | [+1] | |
Mar 07, 2024 | Singapore | Series B | 7031 | ||
Jun 04, 2017 | Israel | Series A | 7348 | [+1] | |
2016 | Singapore | Series A | 7392 |
IPOs and Publicly Listed companies in ZIG Ventures' Portfolio
1 of ZIG Ventures' portfolio company became public - Curiox. It got listed on the Korea Exchange (KRX), in Aug 2023 at marketcap of $79MHere are ZIG Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 10, 2023 | - | - | 2869 |
Acquired companies in ZIG Ventures' Portfolio
1 company from ZIG Ventures' portfolio has been acquired. The most recent acquisition was BELKIN Vision in Jul 2024 by Alcon for $*****.Here are ZIG Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 01, 2024 | Jun 04, 2017 | Series A | 9400 |
Co-investors of ZIG Ventures
Over the past 10 years, 13 investors have co-invested in ZIG Ventures's portfolio companies. This includes funds and angels.
- Invested before ZIG Ventures: LBIC, Europa and 1 other have invested in rounds before ZIG Ventures. There is 1 company where LBIC has invested before ZIG Ventures and 1 company where Europa has invested before ZIG Ventures.
- Top Co-investors of ZIG Ventures: 6 investors entered a company along with ZIG Ventures. These include investors like OCBC (1 company).
- Invested after ZIG Ventures: A total of 4 investors have invested in ZIG Ventures's portfolio after their investments. Top Investors include Clavystbio (1 company), BioLight (1 company) and Santen Pharmaceuticals (1 company).
Recent News related to ZIG Ventures
•
Singapore medtech firm Biobot raises $15.4m for US pushTech in Asia•Jun 29, 2026•Clavystbio, ZIG Ventures, Fogarty Innovation, Biobot Surgical
•
Singapore startup exits in April limited to acquisitionsSingapore Business Review•May 11, 2026•Simple Chain, ZIG Ventures
•
Singapore VC funding drops to 12-month low $39.8m in AprilSingapore Business Review•May 07, 2026•Biobot Surgical, Golden Gate Ventures, ZIG Ventures, Accel
•
HistoIndex Secures SGD9 Million Investment to Drive Next Phase of ExpansionPR Newswire•May 02, 2025•HistoIndex, OCBC, ZIG Ventures, SEEDS Capital and 1 other
•
BIOBOT Surgical Closes $18M Series B FinancingG-MedTech•Mar 08, 2024•Biobot Surgical, ZIG Ventures, Biobot Analytics
•
•
